NL8401221A - Analytische toepassing van fagocyt-cellijnen. - Google Patents

Analytische toepassing van fagocyt-cellijnen. Download PDF

Info

Publication number
NL8401221A
NL8401221A NL8401221A NL8401221A NL8401221A NL 8401221 A NL8401221 A NL 8401221A NL 8401221 A NL8401221 A NL 8401221A NL 8401221 A NL8401221 A NL 8401221A NL 8401221 A NL8401221 A NL 8401221A
Authority
NL
Netherlands
Prior art keywords
cells
phagocyte
analyzed
stimulator
chemiluminescence
Prior art date
Application number
NL8401221A
Other languages
English (en)
Dutch (nl)
Original Assignee
Innovi Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innovi Nv filed Critical Innovi Nv
Priority to NL8401221A priority Critical patent/NL8401221A/nl
Priority to US06/723,100 priority patent/US4737455A/en
Priority to IL74904A priority patent/IL74904A/xx
Priority to EP85104572A priority patent/EP0159653B1/de
Priority to AT85104572T priority patent/ATE56750T1/de
Priority to JP60082106A priority patent/JPS60256377A/ja
Priority to DE8585104572T priority patent/DE3579731D1/de
Publication of NL8401221A publication Critical patent/NL8401221A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/968—High energy substrates, e.g. fluorescent, chemiluminescent, radioactive
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/821—Chemistry: analytical and immunological testing involving complement factors or complement systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NL8401221A 1984-04-16 1984-04-16 Analytische toepassing van fagocyt-cellijnen. NL8401221A (nl)

Priority Applications (7)

Application Number Priority Date Filing Date Title
NL8401221A NL8401221A (nl) 1984-04-16 1984-04-16 Analytische toepassing van fagocyt-cellijnen.
US06/723,100 US4737455A (en) 1984-04-16 1985-04-15 Analytical utilization of phagocyte cell lines
IL74904A IL74904A (en) 1984-04-16 1985-04-15 Continuous phagocyte cell lines and analytical utilization thereof
EP85104572A EP0159653B1 (de) 1984-04-16 1985-04-16 Analytische Verwendung von phagozyten Zellinien
AT85104572T ATE56750T1 (de) 1984-04-16 1985-04-16 Analytische verwendung von phagozyten zellinien.
JP60082106A JPS60256377A (ja) 1984-04-16 1985-04-16 食細胞セルラインの分析への利用
DE8585104572T DE3579731D1 (de) 1984-04-16 1985-04-16 Analytische verwendung von phagozyten zellinien.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8401221 1984-04-16
NL8401221A NL8401221A (nl) 1984-04-16 1984-04-16 Analytische toepassing van fagocyt-cellijnen.

Publications (1)

Publication Number Publication Date
NL8401221A true NL8401221A (nl) 1985-11-18

Family

ID=19843814

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8401221A NL8401221A (nl) 1984-04-16 1984-04-16 Analytische toepassing van fagocyt-cellijnen.

Country Status (7)

Country Link
US (1) US4737455A (de)
EP (1) EP0159653B1 (de)
JP (1) JPS60256377A (de)
AT (1) ATE56750T1 (de)
DE (1) DE3579731D1 (de)
IL (1) IL74904A (de)
NL (1) NL8401221A (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894329A (en) * 1987-02-27 1990-01-16 Serono Pharmaceutical Partners Method of assaying the bioactivity of a thymic extract
GB8729661D0 (en) * 1987-12-19 1988-02-03 Univ Dundee Method of determining phagocyte differentiation/activation
FI910081A7 (fi) * 1988-07-08 1991-01-07 Univ London Solua modifioivien aineiden analyysi
US5612188A (en) * 1991-11-25 1997-03-18 Cornell Research Foundation, Inc. Automated, multicompartmental cell culture system
US5424216A (en) * 1993-08-16 1995-06-13 Jasco Corporation No radical measuring method and apparatus
US6203997B1 (en) 1994-06-08 2001-03-20 Sepsis, Inc. Quantitation of analytes in whole blood
US6306614B1 (en) * 1994-06-08 2001-10-23 Sepsis, Inc. Measurement of analytes in whole blood
US5804370A (en) * 1994-06-08 1998-09-08 Critichem Medical Products Limited Early diagnosis of sepsis utilizing antigen-antibody interactions amplified by whole blood chemiluminescence
US20040053342A1 (en) * 1994-06-08 2004-03-18 Romaschin Alexander D. Measurement of analytes
ATE280202T1 (de) * 1995-08-25 2004-11-15 Grace Gmbh Antikorrosive pigmente und diese enthaltende zusammensetzungen
US6159683A (en) * 1997-12-16 2000-12-12 Spectral Diagnostics, Inc. Method of determining stage of sepsis
AU3081000A (en) * 1998-12-24 2000-07-31 Glaxowellcome B.V. Detection of preactivated phagocytes
AU2001245527A1 (en) * 2000-03-09 2001-09-17 U.S. Army Institute Of Surgical Research Rapid screening procedure for inflammation mediators
US20030118983A1 (en) * 2000-03-09 2003-06-26 Cassidy Richard A. Rapid screening procedure for inflammation mediators
WO2002099133A1 (fr) * 2001-05-31 2002-12-12 Fuso Pharmaceutical Industries, Ltd. Procede ameliore de detection et d'identification de micro-organismes causes d'infections
JPWO2002101037A1 (ja) * 2001-05-31 2005-04-07 扶桑薬品工業株式会社 食細胞機能の評価方法およびその利用
US20050129680A1 (en) * 2001-09-17 2005-06-16 Paul Wentworth Antimicrobial activity of antibodies
US20040116350A1 (en) * 2001-09-17 2004-06-17 Paul Wentworth Jr Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
WO2003027680A2 (en) * 2001-09-28 2003-04-03 Silver Robert B Makrophage-based biosensor for detection of toxic substances
ES2672201T3 (es) 2008-07-16 2018-06-13 Children's Medical Center Corporation Dispositivo de imitación de órganos con microcanales y métodos de uso
DK2681306T3 (en) 2011-02-28 2019-04-23 Harvard College CELL CULTURE SYSTEM
US9725687B2 (en) 2011-12-09 2017-08-08 President And Fellows Of Harvard College Integrated human organ-on-chip microphysiological systems
EP3024582A4 (de) 2013-07-22 2017-03-08 President and Fellows of Harvard College Anordnung mikrofluidischer kartuschen
EP3574985A1 (de) 2013-12-20 2019-12-04 President And Fellows Of Harvard College Organomimetische vorrichtungen und verfahren zur verwendung und herstellung davon
JP2017504320A (ja) 2013-12-20 2017-02-09 プレジデント アンド フェローズ オブ ハーバード カレッジ 低剪断マイクロ流体デバイスならびにその使用および製造の方法
WO2016010861A1 (en) 2014-07-14 2016-01-21 President And Fellows Of Harvard College Systems and methods for improved performance of fluidic and microfluidic systems
US10202569B2 (en) 2015-07-24 2019-02-12 President And Fellows Of Harvard College Radial microfluidic devices and methods of use
EP3512935B1 (de) 2016-09-13 2022-02-23 President and Fellows of Harvard College Verfahren im zusammenhang mit darmorgan-auf-chip

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2302747B1 (fr) * 1975-03-03 1978-09-22 Inst Nat Sante Rech Med Procede d'obtention, a partir de macrophages de mammiferes, d'un produit therapeutique actif, notamment, a l'egard des cellules tumorales humaines et produit therapeutique ainsi obtenu
FI64952C (fi) * 1977-06-15 1984-02-10 Wistar Inst Foerfarande foer framstaellning av genetiskt stabila cellinjer
JPS59169492A (ja) * 1983-03-15 1984-09-25 Asahi Chem Ind Co Ltd ヒト融合細胞からの生理活性物質の産生方法

Also Published As

Publication number Publication date
IL74904A0 (en) 1985-07-31
IL74904A (en) 1989-09-28
ATE56750T1 (de) 1990-10-15
DE3579731D1 (de) 1990-10-25
EP0159653B1 (de) 1990-09-19
US4737455A (en) 1988-04-12
EP0159653A1 (de) 1985-10-30
JPS60256377A (ja) 1985-12-18

Similar Documents

Publication Publication Date Title
NL8401221A (nl) Analytische toepassing van fagocyt-cellijnen.
Tschoepe et al. Evidence for abnormal platelet glycoprotein expression in diabetes mellitus
US5223395A (en) Immunometric assays for tumor necrosis factor-alpha and methods for preventing the loss of biological activity of tumor necrosis factor-alpha in biological samples
Snyderman et al. Deficiency of the fifth component of complement in human subjects: clinical, genetic and immunologic studies in a large kindred
Gewirtz et al. In vitro studies of megakaryocytopoiesis in thrombocytotic disorders of man
Rasmussen et al. Particulate material as a prerequisite for rapid cell multiplication in Tetrahymena cultures
Bjornson et al. Bacteroidaceae in thromboembolic disease: effects of cell wall components on blood coagulation in vivo and in vitro
Rappaport Monolayer Cultures of Trypsinized Monkey Kidney Cells in Synthetic Medium. Application to Poliovirus Synthesis.
Fischer et al. Chemotactically responsive and nonresponsive forms of a continuous human monocyte cell line
JP2651943B2 (ja) 動物細胞膜に蛋白質を挿入する方法
Weinberg et al. Phenotypic characterization of gamma interferon-induced human monocyte polykaryons
CN103667174B (zh) 一种用于处理生物样本的组合物
Bayer et al. Circulating immune complexes in experimental streptococcal endocarditis: a monitor of therapeutic efficacy
John Masawe et al. Growth of bacteria in vitro in blood from patients with severe iron deficiency anemia and from patients with sickle cell anemia
Rickles et al. Persistence of group A streptococci labeled with fluorescein isothiocyanate in inflammatory sites in the heart and muscle of mice and rabbits
Scales et al. Development and passive transfer of immunity to gonococcal infection in guinea pigs
McKinney et al. Non-specificity of Thioflavine-T as an Amyloid Stain
Escolar et al. Ristocetin induces platelet aggregation: a morphological demonstration
Band et al. Observations on induced amitosis in Acanthamoeba
EP0948254A1 (de) Zelltest zur bestätigung enzymatischer aktivität
ALONSO et al. Phagocytic Activity of Three Naegleria Strains in the Presence of Erythrocytes of Various Types 1
JPH0662834A (ja) 白血球細胞溶解剤を含む微生物標品に関する輸送培地
RU2084523C1 (ru) Способ получения питательной среды для культивирования лимфоцитов крови человека
RU2083661C1 (ru) Штамм бактерий neisseria meningitidis серогруппы с, используемый для получения менингококкового адгезина
Clifford et al. Simultaneous measurement of adherence and chemiluminescence by polymorphonuclear leukocytes

Legal Events

Date Code Title Description
A1B A search report has been drawn up
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: INNOGENETICS. N.V. -

BV The patent application has lapsed